Autopsy report · NCT03197805

Assessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer Patients

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.

“Take care recommendations for Her2 equivok patients has changed.”

The sponsor’s own words in the registry.

Life of this trial

Registered 4 months before it started.
Ran for about 1 year 7 months before it stopped.
26 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Na
Sponsor: Centre Jean Perrin
Sponsor type: University, hospital or other
Conditions: Breast Cancer
Interventions: PAM 50 test
Participants: 26
Sites: 16
Countries: France

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.